These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34591150)

  • 1. Efficacy and safety of twice-daily olopatadine-mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis.
    Chen R; Zheng D; Zhang Y; Sima G
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1691-1699. PubMed ID: 34591150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis.
    Segall N; Prenner B; Lumry W; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Sep; 40(5):301-310. PubMed ID: 31248471
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis.
    Andrews CP; Mohar D; Salhi Y; Tantry SK
    Ann Allergy Asthma Immunol; 2020 Feb; 124(2):171-178.e2. PubMed ID: 31734334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.
    Gross GN; Berman G; Amar NJ; Caracta CF; Tantry SK
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):630-638.e3. PubMed ID: 30910440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis.
    Prenner BM; Amar NJ; Hampel FC; Caracta CF; Wu W
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):618-626.e2. PubMed ID: 35926824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study.
    Patel P; Salapatek AM; Tantry SK
    Ann Allergy Asthma Immunol; 2019 Feb; 122(2):160-166.e1. PubMed ID: 30321655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis.
    Lim L; Lipari M; Kale-Pradhan P
    Ann Pharmacother; 2023 May; 57(5):570-578. PubMed ID: 36123818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):224-231. PubMed ID: 29669667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis.
    van Bavel JH; Ratner PH; Amar NJ; Hampel FC; Melchior A; Dunbar SA; Dorinsky PM; Tantry SK
    Allergy Asthma Proc; 2012; 33(5):386-96. PubMed ID: 23026180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review.
    Rodrigo GJ; Neffen H
    Clin Exp Allergy; 2011 Feb; 41(2):160-70. PubMed ID: 21121980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
    Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):232-239. PubMed ID: 29669668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
    Hampel FC; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM
    Allergy Asthma Proc; 2006; 27(3):202-7. PubMed ID: 16913262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis.
    Meltzer EO; Blaiss M; Fairchild CJ
    Allergy Asthma Proc; 2011; 32(3):213-20. PubMed ID: 21477426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
    Bernstein DI; Teper A; Gopalan G; Gates D
    Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.
    Ridolo E; Barone A; Nicoletta F; Paoletti G; Heffler E; Malvezzi L; Canonica GW
    Expert Rev Clin Immunol; 2023 Jun; 19(6):575-584. PubMed ID: 37038974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis.
    Aneeza WH; Husain S; Rahman RA; Van Dort D; Abdullah A; Gendeh BS
    Allergy Rhinol (Providence); 2013; 4(3):e120-6. PubMed ID: 24498516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.